1.00Open1.00Pre Close0 Volume3 Open Interest1.50Strike Price0.00Turnover310.83%IV19.87%PremiumAug 16, 2024Expiry Date0.88Intrinsic Value100Multiplier24DDays to Expiry0.12Extrinsic Value100Contract SizeAmericanOptions Type-0.7494Delta0.6370Gamma0.68Leverage Ratio-0.0031Theta-0.0007Rho-0.51Eff Leverage0.0005Vega
Bionano Genomics Stock Discussion
Benzinga· 1 min ago
Bionano Genomics (NASDAQ:BNGO) reported quarterly losses of $(0.60) per share which beat the analyst consensus estimate of $(0.65) by 7.69 percent. This is a 51.22 percent increase over losses of $(1.23) per share from the same period last year. The company reported quarterly sales of $8.769 million which beat the analyst consensus estimate of ...
Benzinga· just
Bionano Genomics, Inc. (NASDAQ:BNGO) today announced the publication of a study from Penn State College of Medicine that used optical genome mapping (OGM) to search for clinically and biologically relevant genomic variations in pediatric B-cell acute lymphoblastic leukemi...
NEWS
Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing
Bionano Genomics, Inc. (BNGO) announced a study using optical genome mapping (OGM) and whole genome sequencing (WGS) to identify genetic variations in pediatric B-cell acute lymphoblastic leukemia. OGM and WGS together can reveal new therapeutic targets and improve personalized medicine ...
Looks like 2 ?
No comment yet